FDA Approved: EMEND — Original Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

FDA approved EMEND (aprepitant) from Merck as the original application for prevention of acute and delayed chemotherapy-induced nausea and vomiting in cancer pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• EMEND (aprepitant)

Snippet

ORIG AP for EMEND (APREPITANT)